Skip to content

Prospective Multidimensional Precision Prevention and Control Study for the Evolution of Preclinical Rheumatoid Arthritis

Prospective Multidimensional Precision Prevention and Control Study for the Evolution of Preclinical Rheumatoid Arthritis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900022605
Enrollment
Unknown
Registered
2019-04-18
Start date
2016-01-01
Completion date
Unknown
Last updated
2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid arthritis

Interventions

TGP group:Taking total glucosides of white peony 600mg Bid
Control group:none

Sponsors

Department of Rheumatology, West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 75 years; 2. ACPAs-positive; 3. Understanding the whole process of observation and study, volunteering to participate in the clinical trial and having signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnant women, women trying to conceive or lactating women; 2. People with history of chronic diarrhea or peptic ulcer disease during the last year; 3. People with history of mental disease, alcoholism, drug or other substance abuse; 4. People with diagnosis of other rheumatic diseases(including gout, osteoarthritis); 5. People with malignant tumors; 6. People with allergy to the experimental drugs; 7. Any condition in which the researchers consider that people can not be included in the trial.

Design outcomes

Primary

MeasureTime frame
anti CCP antibody;

Countries

China

Contacts

Public ContactLiu Yi

Huaxi Hospital, Sichuan University

hxprera@163.com+86 13880927123

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026